{"disease":{"id":"chronic-kidney-disease-due-to-type-2-diabetes-mellitus","name":"chronic kidney disease due to type 2 diabetes mellitus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07026539","title":"Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06684886","title":"Predictors of Diabetic Foot Outcome in Chronic Kidney Disease Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04361097","title":"Fecal Microbiota Transplantation as a Therapeutic Strategy in the Progression of Chronic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Hospital Universitario Dr. Jose E. Gonzalez","has_results":false},{"nct_id":"NCT06374043","title":"Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT06094920","title":"Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University Medical Center Groningen","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}